Ranking results:

Past rankings:

2018
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	800-900
Total Number of Projects:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 1
As coordinator: 1
As participant: 0
Sole participant: 0
Coordinator / Participant Ratio: ^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:				Projects [No]:
Year:	coordinator^*	participant^*	per partner		as coordinator	as participant
2018	6.013.749	0	3.224.713		1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
CYSTIC FIBROSIS EUROPE EV	1
EUROPEAN CYSTIC FIBROSIS SOCIETY	1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	1
KLINIKUM DER UNIVERSITAET ZU KOELN	1
SMERUD MEDICAL RESEARCH INTERNATIONAL AS	1

Constancy:

Total number of partners: 5
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 5
Frequent / Rare Partner Ratio: 0

Project overview:

Start date	Project	acronym	role	funding	partners
2018-01-01	A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis	OligoGpivotalCF	coordinator	6.013.749	6

ALGIPHARMA AS - Norway